4710:
Update from the US Food and Drug Administration Center for Drug Evaluation and Research (FDA/CDER)
Allergens/Allergy Testing/Allergy Therapeutics
Monday, March 5, 2018: 3:30 PM-4:45 PM
Convention Center, South Concourse, Level 3, S331A
1.25 CME/CE
Workshop
Moderator:
Paul A. Greenberger, MD FAAAAI

Learning Objectives:
  1. Discuss recent issues of scientific importance at the FDA and their clinical implications
3:30 PM
The Year in Review: An Update from the US Food and Drug Administration
Badrul A. Chowdhury, MD PhD FAAAAI
3:50 PM
Question & Answer
3:55 PM
New Approaches for Drug Development in Asthma and Allergic Diseases
Sofia Chaudhry, MD
4:15 PM
Question & Answer
4:20 PM
LABA Safety: An Update from the FDA
Robert Lim, MD
4:40 PM
Question & Answer
See more of: Session